| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,8 M € | -4.4% | 2,9 M € | -0.2% | 2,9 M € | +2.8% | 2,8 M € | -10.2% | 3,2 M € | 0,0 € | — | — | — | — | — | — | — | — | — | 970,6 k € | — | 618,7 k € | +16.4% | 531,3 k € | ||||||||||||||
| Gross margin | 707,1 k € | -5.3% | 746,5 k € | -25.9% | 1,0 M € | +136.5% | 425,9 k € | -50.3% | 857,1 k € | +1.7% | 842,4 k € | +31.3% | 641,4 k € | +27.2% | 504,3 k € | -30.8% | 729,0 k € | -20.3% | 915,1 k € | +0.8% | 907,4 k € | -7.4% | 980,4 k € | +27.3% | 770,3 k € | -16.1% | 917,9 k € | +67.7% | 547,2 k € | +28.4% | 426,1 k € | +8.6% | 392,2 k € | +28.8% | 304,5 k € | +36.5% | 223,2 k € | |
| EBITDA | 179,1 k € | -25.4% | 240,3 k € | -54.5% | 527,7 k € | +1845.9% | -30,2 k € | -107.1% | 425,4 k € | -16.4% | 508,9 k € | +39.0% | 366,0 k € | +45.6% | 251,3 k € | -46.4% | 468,5 k € | -29.5% | 664,5 k € | -7.6% | 718,8 k € | +2.0% | 705,0 k € | +31.0% | 538,0 k € | -19.8% | 670,5 k € | +89.7% | 353,4 k € | +55.5% | 227,3 k € | -11.2% | 255,8 k € | +24.8% | 205,0 k € | +175.0% | 74,5 k € | |
| Operating profit | 6,8 k € | -68.2% | 21,3 k € | -94.5% | 390,7 k € | +341.1% | -162,0 k € | -154.0% | 299,9 k € | -15.8% | 355,9 k € | +60.3% | 222,1 k € | +157.5% | 86,3 k € | -73.6% | 326,4 k € | -36.3% | 512,3 k € | -6.5% | 547,7 k € | +3.0% | 531,8 k € | +57.4% | 337,8 k € | -28.4% | 471,9 k € | +154.8% | 185,2 k € | +238.3% | 54,7 k € | -35.0% | 84,2 k € | +28.4% | 65,6 k € | +234.5% | -48,7 k € | |
| Profit/loss | 2,4 k € | -83.5% | 14,3 k € | -95.8% | 338,1 k € | +307.6% | -162,9 k € | -171.7% | 227,1 k € | -8.6% | 248,3 k € | +62.1% | 153,2 k € | +172.6% | 56,2 k € | -76.5% | 239,4 k € | -27.7% | 331,0 k € | -6.3% | 353,2 k € | +5.8% | 333,8 k € | +54.8% | 215,7 k € | -23.8% | 282,9 k € | +156.8% | 110,2 k € | +2425.3% | 4,4 k € | -87.6% | 35,3 k € | +5.2% | 33,5 k € | +128.3% | -118,7 k € | |
| Equity | 2,8 M € | +0.1% | 2,8 M € | +0.5% | 2,7 M € | +14.1% | 2,4 M € | -6.4% | 2,6 M € | +9.7% | 2,3 M € | +11.9% | 2,1 M € | +7.9% | 1,9 M € | +2.8% | 1,9 M € | +14.9% | 1,6 M € | +25.3% | 1,3 M € | +37.0% | 954,0 k € | +53.8% | 620,2 k € | +53.3% | 404,5 k € | +232.7% | 121,6 k € | +966.1% | 11,4 k € | +62.0% | 7,0 k € | +124.9% | -28,3 k € | +54.3% | -61,8 k € | |
| Total assets | 3,0 M € | +0.0% | 3,0 M € | +3.1% | 2,9 M € | +9.5% | 2,7 M € | -7.5% | 2,9 M € | +3.3% | 2,8 M € | +6.5% | 2,6 M € | +5.9% | 2,5 M € | -4.8% | 2,6 M € | +5.1% | 2,5 M € | +0.6% | 2,5 M € | +16.8% | 2,1 M € | +19.4% | 1,8 M € | -7.8% | 1,9 M € | +4.1% | 1,8 M € | -5.1% | 1,9 M € | -6.8% | 2,1 M € | +6.7% | 1,9 M € | +1.5% | 1,9 M € | |
| Cash | 38,0 k € | -30.6% | 54,7 k € | -50.6% | 110,9 k € | -16.0% | 132,0 k € | -2.5% | 135,4 k € | -41.5% | 231,2 k € | +13.7% | 203,4 k € | +135.1% | 86,5 k € | -22.7% | 111,8 k € | -28.2% | 155,8 k € | +63.0% | 95,6 k € | +116.2% | 44,2 k € | -16.4% | 52,9 k € | -62.7% | 141,6 k € | +166.7% | 53,1 k € | +4.7% | 50,7 k € | -63.3% | 138,3 k € | +495.8% | 23,2 k € | +112.9% | 10,9 k € | |
| Debts | 252,4 k € | -0.8% | 254,3 k € | +43.0% | 177,8 k € | -32.4% | 263,1 k € | -16.4% | 314,7 k € | -29.9% | 448,6 k € | -15.0% | 527,6 k € | -1.2% | 534,2 k € | -24.8% | 710,7 k € | -14.2% | 828,4 k € | -27.7% | 1,1 M € | +0.0% | 1,1 M € | +0.8% | 1,1 M € | -24.3% | 1,5 M € | -12.2% | 1,7 M € | -10.5% | 1,9 M € | -7.1% | 2,1 M € | +4.9% | 2,0 M € | -0.2% | 2,0 M € | |
| Staff | 9,6 | 9,2 | 9,7 | 9,3 | 9,5 | 8,2 | 6,4 | 5,8 | 6,2 | 6,2 | 5,6 | 6,6 | 6,5 | 6,5 | 5,5 | 6,9 | 5,1 | 3,8 | 3,4 | |||||||||||||||||||
Public limited company · Gembloux · incorporated on 16/07/2001 · 9,6 ETP
Public limited company profitable and well capitalised. Cash position declining (-30.6%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
PHARMA MANUFACTURING is a Public limited company incorporated in 2001. Its main activity is: Manufacture of homogenised food preparations and dietetic food. Its registered office is in Gembloux. It employs on average 9,6 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette